Evidence map›Paper›PMID 42404981›Full record

ArticleNeuro-oncology advances

AI-based selection of tumor regions for genomic profiling in neuropathology.

Narmin Ghaffari Laleh, Lukas Friedrich, Fuat Kaan Aras, Katherine J Hewitt, Leonille Schweizer, Zunamys I Carrero, Dilan Savran, Daniel Haag, Silvia Barbosa, Felix Sahm and 1 more

Abstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Narmin Ghaffari LalehElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID https://orcid.org/0000-0003-0889-3352
Lukas FriedrichFrankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.
Fuat Kaan ArasFrankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.
Katherine J HewittElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Leonille SchweizerGerman Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Zunamys I CarreroElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Dilan SavranFrankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.
Daniel HaagFrankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.ORCID https://orcid.org/0009-0006-7105-2977
Silvia BarbosaDept. of Neuropathology, University Hospital Heidelberg, Heidelberg Germany and CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Felix SahmFrankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0001-5441-1962
Jakob Nikolas KatherElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID https://orcid.org/0000-0002-3730-5348

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Automating pathology workflows with deep learning is increasingly feasible and clinically relevant. We present an AI-based method that identifies diagnostically relevant areas directly from H&E-stained slides, trained on 250 glioma cases using sparse, incomplete annotations. First, we show that attention-based multiple instance learning achieves accurate predictions despite noisy labels, easing the annotation burden. Second, the model highlights tumor regions with high cellularity or grade, offering reproducible guidance for tissue selection. In a prospective evaluation, AI-selected regions achieved a mean Dice score of 0.743 [±0.077], supporting integration into neuropathology workflows as reliable guidance for molecular diagnostics.

Indexed as

gliomamolecular diagnosticsmultiple instance learningtumor region segmentationweakly supervised learning

Identifiers

PMID42404981
PMCPMC13332501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.